FDA's Pazdur Jumps Over To New 'Moonshot' Role
This article was originally published in The Pink Sheet Daily
Creation of agency's new Oncology Center of Excellence means the Office of Hematology and Oncology Products, often seen as FDA's model product review shop, needs new leadership – at least temporarily.
You may also be interested in...
Commissioner Gottlieb says new centers would follow template of Oncology Center of Excellence.
Oncology Center of Excellence Director Richard Pazdur says agency invites sponsors to present about molecules under development to learn more about future plans.
Deputy Office of New Drugs director says IND evaluation and post-market surveillance could be part of restructuring effort along with changes to application review.